Orin Green Financial’s Pacific Biosciences PACB Stock Holding History

Orin Green Financial’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,000	Closed	-$13.7K	–	79
2025 Q1	$13.7K	Buy	+12,000	New	+$18.4K	0.01%	76
2024 Q4	–	Sell	-12,000	Closed	-$23.4K	–	78
2024 Q3	$20.4K	Hold	12,000	–	–	0.01%	83
2024 Q2	$16.4K	Buy	+12,000	New	+$24.2K	0.01%	77
2024 Q1	–	Sell	-12,000	Closed	-$70.3K	–	77
2023 Q4	$118K	Hold	12,000	–	–	0.06%	75
2023 Q3	$100K	Hold	12,000	–	–	0.06%	69
2023 Q2	$160K	Hold	12,000	–	–	0.08%	66
2023 Q1	$139K	Hold	12,000	–	–	0.08%	65
2022 Q4	$98.2K	Hold	12,000	–	–	0.06%	64
2022 Q3	$70K	Hold	12,000	–	–	0.05%	61
2022 Q2	$62K	Hold	12,000	–	–	0.04%	65
2022 Q1	$109K	Buy	+12,000	New	+$138K	0.07%	65

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orin Green Financial's PACB Position: Q2 2025 in Review

Orin Green Financial sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 12,000 shares — an estimated $13.7K sold.

Orin Green Financial first reported a position in PACB in Q1 2022 and held it in 11 quarters. The position peaked at $160K in Q2 2023. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

Orin Green Financial reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
Orin Green Financial sold 12,000 Pacific Biosciences shares in Q2 2025, an estimated $13.7K.
Orin Green Financial first reported a position in Pacific Biosciences in Q1 2022 and held it in 11 quarters.
Orin Green Financial's Pacific Biosciences position peaked at $160K in Q2 2023.
207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Orin Green Financial's 13F filing for Q2 2025, filed 29 Jul 2025.